This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Osteitis due to dental implant
ST19_OSTITIS_DENTAL_IMPLANT
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
206 |
4. Check minimum number of eventsNone |
206 |
5. Include endpointsNone |
206 |
6. Filter based on genotype QC (FinnGen only) |
206 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- First used in FinnGen datafreeze
- DF6
Similar endpoints
↥List of similar endpoints to
Osteitis due to dental implant
based on the number of shared cases.
Similar with more cases:
- Complications of internal orthopaedic prosthetic devices, implants and grafts
- Complications of surgical and medical care, not elsewhere classified
- Injury, poisoning and certain other consequences of external causes
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 206 | 124 | 82 |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | 68.65 | 69.75 | 66.98 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 174
- Matched controls
- 1737
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
T84.62
ICD-10 Finland
Osteitis associated with dental implants
+∞
251.7
174
*
SAA03
NOMESCO Finland
Extended examination of mouth
21.3
58.8
154
462
T84.60
ICD-10 Finland
Gingivitis associated with dental implants
377.5
55.6
53
*
EBB10
NOMESCO Finland
Insertion of dental implant
76.2
51.6
57
11
ECU00
NOMESCO Finland
Removal of implant or external fixation device from alveoli
650.4
51.2
48
*
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
14.9
50.0
97
135
SXB00
NOMESCO Finland
Removeal of sutres from oral mucosa
20.2
46.0
73
60
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
11.1
44.5
134
404
SBB00
NOMESCO Finland
Fotograf of mouth and teeth
34.3
42.2
55
23
Y88.3
ICD-10 Finland
Sequelae of surgical and medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
39.4
40.6
51
18
EBB15
NOMESCO Finland
Insertion of dental implant abutment
109.6
39.8
42
5
EBB11
NOMESCO Finland
Insertion of additional dental implant in one session
171.7
39.6
40
*
ECA55
NOMESCO Finland
Complicated parodontal operation
+∞
36.8
34
*
SDA12
NOMESCO Finland
Treatment of complicated periodontal disease
49.7
35.3
42
11
SBB10
NOMESCO Finland
Teeth copy
20.1
35.0
54
38
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
7.9
33.1
136
540
SPC20
NOMESCO Finland
Attachment of crone of tooth to implant
86.8
32.2
35
5
Y83.1
ICD-10 Finland
Surgical operation with implant of artificial internal device as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
56.2
31.0
36
8
Z96.5
ICD-10 Finland
Presence of tooth-root and mandibular implants
101.2
31.0
33
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
18.5
29.2
46
33
K08.2
ICD-10 Finland
Atrophy of edentulous alveolar ridge
40.8
29.1
36
11
SAA04
NOMESCO Finland
Special inverstigation of mouth
15.8
29.1
49
42
SPA20
NOMESCO Finland
Selection and insertion of implantdistans
93.3
28.8
31
*
SBA00
NOMESCO Finland
Microbiological examinations
24.3
28.2
40
21
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
55.5
27.6
32
7
ECB40
NOMESCO Finland
Surgical treatment of fracture of alveolus
317.2
27.5
27
*
K05.31
ICD-10 Finland
Periodontitis pronounced
8.8
27.2
65
110
SPA00
NOMESCO Finland
Changing form of teeth in prepation for prothetic work
14.5
26.4
46
42
SPF00
NOMESCO Finland
Repatation of teeth prosthesis
19.9
25.1
38
24
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
10.5
23.3
48
61
EBA10
NOMESCO Finland
Surgical removal of tooth
7.9
21.4
53
91
ECA70
NOMESCO Finland
Regenerative parodontal operation or gingiva and alveolus transplantation
125.0
21.1
22
*
Y89.9
ICD-10 Finland
Sequelae of unspecified external cause
31.6
20.8
27
10
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
33.6
20.3
26
9
SXC03
NOMESCO Finland
Other oral or dental procedure
52.6
19.7
23
5
SPF20
NOMESCO Finland
Temporary soling for filling
50.0
18.7
22
5
J01FF01
ATC
clindamycin; systemic
4.3
17.3
87
327
SDA04
NOMESCO Finland
Very demanding parodonthologic therapy
4.4
16.7
77
267
SDA03
NOMESCO Finland
Demanding parodonthologic therapy
4.0
16.6
99
433
EB1AA
NOMESCO Finland
Tooth X-ray examination
4.1
15.9
131
744
ECA50
NOMESCO Finland
Parodontal operation
42.3
15.7
19
5
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
8.4
15.0
34
49
SPF40
NOMESCO Finland
Removal and reattachment with cement of tooth crone or short bridge
14.4
14.9
25
20
SAA02
NOMESCO Finland
Basic examination of mouth
4.1
14.6
139
856
WZB00
NOMESCO Finland
Telephone receipt or other advice
3.8
14.5
80
317
K05.30
ICD-10 Finland
Periodontitis complex
4.9
14.0
51
136
WX110
NOMESCO Finland
Local anesthesy
4.3
14.0
146
952
SPA10
NOMESCO Finland
Setting attachments on tooth or implanted bracket or imblant based structures
81.3
13.8
15
*
EFB40
NOMESCO Finland
Removal of internal or external fixation device from facial bones
+∞
13.7
13
*
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
43.8
13.4
16
*
SPA02
NOMESCO Finland
Preparation for dental prosthetics
14.6
13.3
22
17
K00.00
ICD-10 Finland
Hypodontia
75.5
12.8
14
*
SXC05
NOMESCO Finland
Other oral or dental procedure
8.1
12.8
29
42
T84.61
ICD-10 Finland
Gingival growth associated with dental implants
+∞
12.6
12
*
T84.64
ICD-10 Finland
Other infection or inflammatory reaction associated with dental implants
139.6
12.6
13
*
SDA05
NOMESCO Finland
Very demanding and lengthy parodonthologic therapy
7.3
12.0
29
46
J01CE02
ATC
phenoxymethylpenicillin; oral
3.5
11.9
138
904
Y98
ICD-10 Finland
Lifestyle-related condition
+∞
11.6
11
*
SAA01
NOMESCO Finland
Simple examination of mouth
3.6
11.6
143
971
SDA02
NOMESCO Finland
Parodonthologic therapy
3.2
11.5
84
396
SPF30
NOMESCO Finland
Soling for prothesis
12.4
11.4
20
18
SPF10
NOMESCO Finland
Demanding repatation of teeth prosthesis
17.0
11.1
17
11
SPA41
NOMESCO Finland
Precision impression for fixed dental prosthesis
34.9
10.5
13
*
EB1BA
NOMESCO Finland
Extensive intraoral X-ray examination
25.2
10.4
14
6
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
10.5
10.1
19
20
SPF50
NOMESCO Finland
Removal and reattachment with cement of tooth bridnge
27.9
10.0
13
5
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
5.2
9.9
31
69
Z97.2
ICD-10 Finland
Presence of dental prosthetic device (complete)(partial)
9.5
9.6
19
22
ECB20
NOMESCO Finland
Oral alveoplasty
23.2
9.5
13
6
SXC04
NOMESCO Finland
Other oral or dental procedure, extensive
38.9
9.1
11
*
SPC01
NOMESCO Finland
Fixed dental crown
19.9
9.1
13
7
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
52.7
8.8
10
*
Z01.2
ICD-10 Finland
Dental examination
2.6
8.6
92
520
WX199
NOMESCO Finland
Other local analgesia
8.6
8.6
18
23
SPA05
NOMESCO Finland
Guiding rail
94.4
8.5
9
*
EEC45
NOMESCO Finland
Reconstruction of maxilla using bone graft
+∞
8.4
8
*
EMAK
NOMESCO Finland
NA
7.9
8.2
18
25
SPF03
NOMESCO Finland
Impression for dental prosthesis repair, demanding
35.1
8.2
10
*
SXC02
NOMESCO Finland
Other oral or dental procedure, restricted
7.2
8.1
19
29
ECA35
NOMESCO Finland
Complicated excision of lesion of gingiva
47.1
7.8
9
*
SDA13
NOMESCO Finland
Treatment of complicated periodontal disease, extensive and demanding
47.1
7.8
9
*
SPA60
NOMESCO Finland
Fitting of intermediary dental prosthesis structures, 1 to 3 units
12.6
7.7
13
11
SBB20
NOMESCO Finland
Tooth X-ray examination in conjunction with visit to dentist
19.4
7.7
11
6
C03.1
ICD-10 Finland
Malignant neoplasm: Lower gum
83.5
7.5
8
*
EBA00
NOMESCO Finland
Extraction of tooth
2.5
7.5
75
400
SPC10
NOMESCO Finland
Attachment of standard crone of tooth
10.0
7.4
14
15
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
4.0
7.4
29
82
SPD10
NOMESCO Finland
Fitting and preparation of partial total prothesis of teeth attached with implants
+∞
7.3
7
*
SPF41
NOMESCO Finland
Repair of dental crown, bridge or implant structure, standard
16.6
7.3
11
7
K07.13
ICD-10 Finland
Retrognaty, mandibular
23.6
6.7
9
*
SPF11
NOMESCO Finland
Fitting of dental prosthesis
23.6
6.7
9
*
K13.29
ICD-10 Finland
Indefinite leukoplakia
15.0
6.5
10
7
YEA05
NOMESCO Finland
Excision of gingival or connective tissue for transplantation
+∞
6.3
6
*
EFU00
NOMESCO Finland
Removal of implant or external fixation device from jaws
+∞
6.3
6
*
ECB30
NOMESCO Finland
Alveoplasty using graft of skin or mucosa
+∞
6.3
6
*
GBB00
NOMESCO Finland
Tracheostomy
27.8
6.3
8
*
J01DB01
ATC
cefalexin; oral
2.8
6.3
150
1199
K04.5
ICD-10 Finland
Chronic apical periodontitis
2.4
6.2
60
309
ECA30
NOMESCO Finland
Excision of lesion of gingiva
9.1
6.2
12
14
EB1CA
NOMESCO Finland
Tooth X-ray additional picture
3.7
6.1
26
79
SPAT1153
SPAT
Removal of sutures
2.3
6.1
69
382
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3026389) Candida sp identified in Specimen by Organism specific culture
19
18
11.53
17.58
2.1
1.3
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
121
809
2.20
7.03
4.4
4.2
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
34
139
2.73
6.00
11.4
6.9
mmol/l
9.1
10.1
0.31
34
131
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
197
1738
4.05
5.86
21.6
14.8
mg/l
20.7
22.6
0.53
168
1361
(3021960) Folate [Moles/volume] in Serum or Plasma
75
452
2.04
5.37
1.6
1.5
nmol/l
20.7
21.6
0.17
63
380
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
110
760
1.96
5.31
1.9
2.0
pmol/l
90.3
98.5
0.98
55
361
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
70
416
2.03
5.18
2.5
2.4
—
—
—
0
0
(3019225) pH of Specimen
38
177
2.41
5.12
5.6
4.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
107
744
1.91
4.96
8.1
8.3
inr
1.3
1.2
0.22
26
207
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
124
916
1.89
4.66
13.4
6.8
mmol/l
1.2
1.2
0.02
105
777
(3037467) Urinalysis macro (dipstick) panel - Urine
153
1219
1.99
4.48
5.9
4.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
85
563
1.87
4.46
2.7
2.4
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
47
256
2.08
4.33
2.2
2.1
—
—
—
0
0
(3013512) EKG study
84
559
1.85
4.31
4.8
4.1
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
6
12.01
4.30
5.1
2.2
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
38
192
2.20
4.23
1.7
1.6
—
—
—
0
0
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
115
847
1.81
4.20
11.6
6.0
mmol/l
1.2
1.2
0.19
100
767
(3024561) Albumin [Mass/volume] in Serum or Plasma
110
801
1.80
4.16
7.1
4.5
g/l
34.9
35.6
0.66
103
747
(3019550) Sodium [Moles/volume] in Serum or Plasma
199
1822
3.71
4.07
25.9
17.6
mmol/l
139.5
139.7
0.58
194
1773
(3023520) Reticulocytes [#/volume] in Blood
33
160
2.27
4.04
2.6
2.7
e9/l
69.6
70.3
0.05
25
131
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
167
1394
2.05
3.98
11.4
7.5
u/l
75.7
77.9
0.32
161
1296
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
126
966
1.78
3.90
8.2
6.3
umol/l
9.6
11.0
2.21
120
916
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
11
30
3.82
3.69
1.5
1.8
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
42
233
2.01
3.65
1.8
1.5
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
10
26
3.99
3.56
1.5
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
99
722
1.71
3.54
2.5
2.1
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
31
155
2.18
3.53
7.1
3.7
mmol/l
2.7
2.3
0.32
24
124
(3023103) Potassium [Moles/volume] in Serum or Plasma
198
1825
3.19
3.46
26.8
17.6
mmol/l
4.0
4.0
0.52
193
1774
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
13
42
3.24
3.43
1.7
1.7
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
31
158
2.13
3.36
7.1
3.6
kpa
5.9
5.9
0.08
31
151
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
39
218
1.97
3.31
11.1
8.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
10
28
3.70
3.24
1.5
1.3
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
115
894
1.65
3.09
8.7
5.6
e9/l
0.2
0.2
0.25
107
789
(3015377) Calcium [Moles/volume] in Serum or Plasma
87
631
1.66
3.07
4.3
3.4
mmol/l
2.3
2.4
1.43
73
552
(3006315) Basophils [#/volume] in Blood
112
867
1.64
3.04
8.1
5.5
e9/l
0.0
0.0
0.03
105
752
(40768446) Kidney Pathology biopsy report
5
5
10.20
2.99
1.6
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
56
364
1.74
2.95
1.6
1.7
nmol/l
1247.4
1183.4
0.20
43
263
(3001604) Monocytes [#/volume] in Blood
111
863
1.62
2.92
8.1
5.5
e9/l
0.7
0.6
0.82
104
745
(3019198) Lymphocytes [#/volume] in Blood
113
883
1.62
2.91
8.2
5.6
e9/l
3.7
2.0
0.45
105
782
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
157
1334
1.74
2.90
4.8
3.9
pmol/l
14.9
14.8
0.08
140
1195
(3022217) INR in Platelet poor plasma by Coagulation assay
41
244
1.85
2.89
34.9
20.1
inr
1.1
1.3
—
6
33
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
6
10
6.14
2.71
1.2
1.1
—
—
—
0
0
(44813793)
6
10
6.14
2.71
1.0
1.0
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
56
372
1.69
2.71
1.8
1.9
pmol/l
458.6
450.5
0.09
47
306
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
12
43
2.90
2.69
1.7
1.7
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
13
49
2.76
2.68
1.8
1.4
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
38
227
1.83
2.64
11.1
6.3
mmol/l
103.5
103.5
0.00
38
219
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
45
288
1.72
2.48
2.6
1.9
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
181
1627
1.93
2.48
5.7
4.7
mu/l
2.0
1.9
0.16
164
1469
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
15
64
2.45
2.45
2.3
2.5
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
77
571
1.56
2.35
9.9
5.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
24
128
1.99
2.33
2.5
3.0
ml/min/173m2
64.4
58.6
—
10
58
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
8
23
3.58
2.29
1.8
1.5
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
36
222
1.75
2.25
2.9
2.6
%
1.8
1.8
0.21
29
201
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
6
14
4.38
2.16
1.5
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
194
1807
2.26
2.08
20.1
13.8
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
7
20
3.58
2.07
1.4
2.1
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
24
134
1.90
2.06
3.2
2.6
kpa
3.8
4.4
1.10
24
127
(3029634) Reagin Ab [Titer] in Serum by VDRL
6
15
4.09
2.05
2.0
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
34
212
1.72
2.05
1.4
1.3
titre
1229.1
504.6
0.59
11
52
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
21
112
1.97
2.05
2.5
1.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
11
44
2.58
2.05
2.6
2.5
u/ml
0.3
0.4
—
5
18
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
187
1724
1.92
1.99
5.4
4.7
mmol/l
4.6
4.6
0.16
173
1578
(44790048)
7
21
3.41
1.98
1.9
1.7
—
—
—
0
0
(44790049)
7
21
3.41
1.98
1.9
1.7
—
—
—
0
0
(44790047)
7
21
3.41
1.98
1.9
1.7
—
—
—
0
0
(44806118)
7
21
3.41
1.98
1.9
1.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
91
721
1.47
1.96
4.8
4.0
ng/l
36.0
86.5
0.56
65
535
(3042631) Mycobacterium sp identified in Specimen
8
27
3.04
1.95
2.4
3.3
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
33
2.80
1.95
2.1
1.6
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
13
58
2.32
1.95
2.9
2.0
ug/l
290.3
327.6
0.09
13
52
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
16
3.83
1.95
1.7
1.5
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
15
72
2.17
1.91
2.3
2.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
181
1657
1.76
1.91
4.9
4.2
mmol/l
1.2
1.3
0.81
166
1492
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
7
22
3.26
1.89
1.4
2.0
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
34
2.72
1.89
1.4
1.7
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
13
59
2.28
1.88
8.5
12.2
%
1.7
1.6
0.06
13
54
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
60
440
1.51
1.88
2.5
2.0
mg/l
2.6
3.2
1.53
54
369
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
17
87
2.04
1.86
19.2
13.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
17
3.60
1.85
1.3
1.2
—
—
—
0
0
(3002030) Lymphocytes/100 leukocytes in Blood
102
833
1.44
1.84
9.1
5.8
%
28.6
27.8
0.25
93
763
(3021788) Differential panel - Synovial fluid
7
23
3.11
1.81
2.1
1.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
7
23
3.11
1.81
1.6
2.5
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
149
1310
1.50
1.81
6.3
4.2
mm/h
13.4
12.6
0.32
139
1186
(3047181) Lactate [Moles/volume] in Blood
11
47
2.42
1.81
10.7
15.7
mmol/l
1.5
1.2
0.40
11
42
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
75
582
1.45
1.76
3.5
3.1
ng/l
2352.6
1084.1
0.68
69
496
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
184
1701
1.77
1.75
5.5
4.9
mmol/l
6.0
6.1
0.26
174
1543
(3023368) Bacteria identified in Blood by Culture
64
482
1.48
1.75
5.9
4.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
189
1761
1.89
1.75
5.9
5.3
mmol/l
2.7
2.7
0.07
175
1603
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
19
104
1.91
1.74
1.8
1.3
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
93
753
1.43
1.73
2.5
2.2
nmol/l
78.8
78.8
0.00
84
654
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
14
69
2.10
1.69
2.3
1.8
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
33
216
1.63
1.67
13.1
8.4
kpa
5.2
5.2
0.05
33
209
(3027801) Oxygen [Partial pressure] in Arterial blood
33
216
1.63
1.67
13.1
8.4
kpa
11.7
12.0
0.15
33
209
(3021879) Hepatitis B virus core Ab [Presence] in Serum
20
113
1.85
1.67
2.0
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
6
19
3.22
1.67
1.2
1.6
—
—
—
0
0
(4062490)
6
19
3.22
1.67
1.5
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
75
587
1.44
1.67
4.3
3.0
mmol/l
7.0
7.3
0.20
59
487
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
7
25
2.86
1.66
1.1
1.8
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
30
192
1.66
1.66
14.1
9.0
%
96.4
96.1
0.13
30
187
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
12
56
2.21
1.64
1.1
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
20
114
1.84
1.63
2.1
2.8
e9/l
3.3
3.6
0.21
13
82
(3020682) Albumin/Creatinine [Ratio] in Urine
77
608
1.43
1.63
5.2
3.9
mg/mmol
17.6
8.2
0.41
48
382
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
7
26
2.75
1.59
1.4
1.8
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
99
821
1.40
1.57
9.2
5.6
%
55.3
57.2
0.82
91
759
(46235355) HIV 1 and 2 tests - Meaningful Use set
35
237
1.57
1.55
3.1
1.7
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
16
86
1.93
1.55
2.9
2.6
%
1.1
1.3
0.41
16
86
(3003396) Base excess in Arterial blood by calculation
33
221
1.59
1.53
13.1
8.3
mmol/l
1.3
1.4
0.05
27
182
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
7
27
2.65
1.53
1.6
1.3
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
72
568
1.41
1.51
4.5
3.1
mg/l
118.3
278.4
0.45
43
364
(3022096) Basophils/100 leukocytes in Blood
95
786
1.39
1.51
9.1
5.6
%
0.6
0.7
0.09
88
720
(3003694) ABO and Rh group [Type] in Blood
59
449
1.44
1.51
1.5
1.4
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
98
817
1.38
1.48
9.7
5.9
%
9.3
8.6
0.92
91
755
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
75
598
1.40
1.48
4.1
3.1
u/l
30.4
32.1
0.12
68
568
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
127
1105
1.39
1.48
3.3
3.2
u/l
75.4
47.8
0.42
119
1022
(4034850)
11
52
2.18
1.47
8.6
12.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
6
22
2.78
1.44
1.8
1.5
—
—
—
0
0
(3006504) Eosinophils/100 leukocytes in Blood
97
810
1.37
1.44
9.3
5.6
%
2.9
2.8
0.21
90
742
(3048929) Epstein Barr virus Ab [Presence] in Serum
9
40
2.31
1.42
1.6
1.3
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
54
409
1.43
1.41
4.7
4.4
%
19.5
22.1
0.77
25
194
(3023419) Bacteria identified in Sputum by Culture
7
29
2.46
1.40
3.1
2.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
41
295
1.49
1.39
5.1
3.3
mmol/l
0.8
0.8
0.69
36
277
(3000991) Gas panel - Venous blood
23
144
1.67
1.39
18.3
7.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
110
941
1.36
1.39
2.8
2.8
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
6
23
2.66
1.37
1.5
1.8
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
183
1713
1.61
1.35
5.4
4.6
mmol/l
1.5
1.5
0.09
169
1554
(40761535) Cells panel - Urine sediment
23
146
1.65
1.33
5.7
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
103
877
1.35
1.32
5.8
3.9
estimate
0.0
0.0
0.00
20
149
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
178
1658
1.54
1.32
19.3
14.3
ml/min/173m2
77.0
77.6
0.11
149
1341
(3004616) Nuclear Ab [Presence] in Serum
6
24
2.54
1.31
1.2
1.2
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.4
2.0
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.4
2.0
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
5
18
2.82
1.29
1.4
2.0
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
5
18
2.82
1.29
1.2
1.2
—
39938.0
—
0
10
(3005719) IgG [Mass/volume] in Serum or Plasma
22
140
1.64
1.26
3.5
2.6
g/l
8.9
9.9
0.47
22
126
(3019060) Gas panel - Arterial blood
20
124
1.68
1.26
7.9
7.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
69
556
1.36
1.25
3.6
3.2
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
36
260
1.47
1.20
4.4
2.1
%
20.0
22.6
0.60
26
217
(3044889) 12 lead EKG panel
139
1252
1.34
1.15
4.7
4.1
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
8
40
2.04
1.13
1.0
1.3
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
18
112
1.67
1.13
2.8
2.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
50
389
1.38
1.12
5.7
4.2
kg/l
1.0
1.0
—
10
53
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
282
1.43
1.11
1.4
1.3
iu/ml
11.4
39.4
2.99
14
97
(3030905) Polymorphonuclear cells [#/volume] in Blood
7
32
2.23
1.09
2.4
3.1
e9/l
4.7
4.8
—
7
32
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
7
32
2.23
1.09
2.7
3.6
%
62.3
61.3
—
7
32
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
10
52
1.97
1.08
1.2
1.8
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
7
33
2.16
1.06
5.6
3.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
46
2.00
1.05
2.6
1.2
—
—
—
0
0
(4035726)
24
164
1.52
1.05
1.4
1.4
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
5
22
2.30
1.04
1.2
1.9
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
22
2.30
1.04
1.2
1.2
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
7
34
2.10
1.04
1.0
1.5
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
48
376
1.36
1.03
1.6
1.8
mg/l
0.7
1.2
2.14
38
303
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
28
199
1.47
1.02
2.7
1.7
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
36
269
1.41
1.02
1.3
1.3
u/ml
5.4
11.2
0.62
16
93
(40758558) Short blood count panel - Blood
57
461
1.33
0.99
7.9
6.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
12
69
1.78
0.99
1.1
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
9
50
1.84
0.98
1.2
1.2
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
7
36
1.98
0.98
2.3
1.3
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
18
117
1.59
0.97
11.2
10.2
mmol/l
25.2
24.7
0.21
18
112
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
7
37
1.92
0.95
1.0
2.5
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
99
867
1.27
0.94
5.8
3.9
estimate
0.0
0.0
0.00
20
163
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
27
2.26
0.94
1.5
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
27
2.26
0.94
1.5
1.6
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
27
2.26
0.94
1.5
1.6
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
25
177
1.47
0.94
3.2
1.5
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
46
364
1.34
0.93
4.2
3.2
ng/l
654.6
190.1
0.34
38
296
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
6
28
2.18
0.92
1.0
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
63
523
1.29
0.91
5.1
4.9
ug/l
2.4
2.0
0.43
56
459
(3002256) Pathology report gross observation
29
213
1.42
0.91
1.4
1.3
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
84
726
1.27
0.88
3.7
2.6
ug/l
167.1
121.4
0.54
78
657
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
30
2.03
0.87
1.8
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
6
30
2.03
0.87
1.7
1.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
6
31
1.96
0.85
1.0
1.4
nmol/l
0.5
0.5
—
6
26
(3028026) IgM [Mass/volume] in Serum or Plasma
17
114
1.54
0.82
1.8
1.8
g/l
0.8
1.4
1.22
17
103
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
15
99
1.56
0.78
3.2
2.0
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
173
1644
1.33
0.75
7.6
6.2
mmol/mol
39.9
40.6
0.46
161
1518
(1616796) Gas panel - Central venous blood
7
40
1.78
0.72
3.3
2.6
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
5
26
1.95
0.71
1.0
1.2
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
42
1.69
0.69
1.1
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
42
1.69
0.69
2.0
1.7
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
5
27
1.87
0.69
2.0
1.1
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
5
27
1.87
0.69
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
5
27
1.87
0.69
1.6
1.6
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
25
189
1.37
0.68
5.0
3.4
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
77
676
1.22
0.67
6.3
4.0
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
15
103
1.49
0.67
1.3
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
5
28
1.80
0.66
1.6
1.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
15
104
1.48
0.64
2.5
1.6
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
96
865
1.21
0.64
7.3
5.2
estimate
0.0
0.0
0.00
19
159
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
26
201
1.34
0.63
3.0
1.8
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
18
131
1.41
0.61
6.8
4.1
%
1.2
0.4
—
5
35
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
30
238
1.30
0.61
1.5
1.4
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
0
20
0.00
0.60
0.0
2.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
8
52
1.56
0.60
2.3
4.6
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
56
482
1.22
0.59
5.3
3.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
17
124
1.40
0.58
2.2
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
65
570
1.21
0.57
2.7
2.5
u/l
54.1
56.4
0.28
60
522
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
8
55
1.47
0.57
1.3
1.7
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
10
65
1.57
0.56
1.3
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
30
243
1.27
0.53
5.0
4.5
%
32.1
32.2
0.01
18
162
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
7
45
1.57
0.49
2.0
1.6
—
0.1
—
0
8
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
24
297
0.78
0.49
5.2
3.0
e6/l
3.7
2.5
0.19
17
155
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
5
83
0.59
0.46
1.0
1.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
65
582
1.17
0.45
9.4
3.8
ph
7.4
7.4
—
9
112
(40761536) Microorganisms panel - Urine sediment
19
149
1.30
0.43
8.3
3.6
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
6
91
0.65
0.43
1.5
3.3
u/ml
13.0
1693.3
—
6
76
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
5
31
1.63
0.43
1.0
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
20
159
1.29
0.42
5.9
2.9
g/l
66.1
66.3
0.05
20
143
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(4024509)
0
17
0.00
0.41
0.0
1.3
—
—
—
0
0
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
274.6
—
0
11
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
0
17
0.00
0.41
0.0
1.0
—
639.4
—
0
11
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
0
17
0.00
0.41
0.0
1.1
—
38.0
—
0
10
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
5
34
1.48
0.40
1.4
1.7
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
19
151
1.28
0.40
6.7
4.1
%
1.0
0.7
—
6
51
(3034274) Bile acid [Moles/volume] in Serum --fasting
0
18
0.00
0.40
0.0
2.3
—
5.3
—
0
12
(3011397) Hemoglobin [Presence] in Urine by Test strip
46
404
1.18
0.40
5.7
3.9
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
42
366
1.19
0.40
6.5
5.2
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
5
35
1.44
0.39
1.2
1.1
u/l
12.3
5.5
—
5
28
(3013139) Helicobacter pylori Ag [Presence] in Stool
13
98
1.35
0.38
1.2
1.3
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
5
36
1.40
0.38
2.2
3.4
umol/l
33.8
36.5
—
5
29
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
6
41
1.48
0.36
1.5
1.2
e6/l
1808.2
212.9
—
6
34
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
6
44
1.37
0.34
1.7
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
34
295
1.18
0.34
2.4
2.9
ug/l
0.8
0.8
0.05
23
189
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
6
45
1.34
0.34
6.7
2.4
mg/l
1.7
1.7
—
6
39
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
6
47
1.28
0.32
1.2
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
12
93
1.31
0.30
12.0
3.5
—
—
—
0
0
(4010399)
17
139
1.24
0.30
2.1
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
7
57
1.24
0.29
1.6
1.5
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
12
94
1.29
0.28
2.4
3.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
17
140
1.23
0.28
7.3
4.2
%
0.5
0.2
—
6
44
(3043409) Potassium [Moles/volume] in Arterial blood
8
67
1.20
0.26
5.9
3.5
mmol/l
3.8
4.0
—
8
60
(3020891) Body temperature
9
74
1.23
0.25
7.0
4.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
157
1526
1.12
0.25
23.0
15.7
%
36.7
39.9
2.18
101
1073
(3017446) Testosterone [Moles/volume] in Serum or Plasma
13
105
1.25
0.25
2.2
2.2
nmol/l
13.2
12.6
0.11
13
98
(40768797) Stomach Pathology biopsy report
29
256
1.15
0.25
1.3
1.2
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
28
316
0.87
0.24
4.4
2.8
e6/l
0.9
1.0
0.10
21
175
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
24
209
1.17
0.24
4.3
4.5
ug/l
7.5
28.2
0.49
18
172
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
5
39
1.29
0.23
1.4
1.4
—
—
—
0
0
(3022145) Colonoscopy Study observation
19
220
0.85
0.22
1.2
1.2
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
51
472
1.11
0.22
7.9
4.2
estimate
0.1
0.0
0.48
19
160
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
5
42
1.20
0.21
2.2
1.4
—
—
—
0
0
(3035880) pH of Pleural fluid
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.3
—
6.7
—
0
11
(3044242) Glucose [Moles/volume] in Arterial blood
0
11
0.00
0.21
0.0
1.8
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
10
0.00
0.21
0.0
3.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
27
240
1.14
0.21
1.4
1.4
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
0
12
0.00
0.21
0.0
2.3
—
6.9
—
0
12
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.6
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
3.2
—
41.0
—
0
6
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
13
0.00
0.21
0.0
2.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
6
48
1.26
0.20
4.8
1.8
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
6
48
1.26
0.20
2.3
1.8
—
—
—
0
0
(3008898) HLA-B27 [Presence]
6
48
1.26
0.20
1.3
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
0
14
0.00
0.20
0.0
1.5
—
—
—
0
0
(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration
0
14
0.00
0.20
0.0
2.1
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
10
122
0.81
0.19
1.4
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
16
137
1.18
0.19
4.1
2.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
7
59
1.19
0.18
1.1
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
51
477
1.09
0.18
1.5
1.6
mmol/l
1.4
1.4
0.00
44
396
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
7
61
1.15
0.17
1.4
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
7
61
1.15
0.17
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
7
62
1.13
0.17
1.4
1.2
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
5
69
0.72
0.17
7.2
2.3
g/l
0.0
0.5
—
5
60
(3004716) Salmonella sp identified in Stool by Organism specific culture
11
92
1.21
0.16
1.5
1.3
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
80
0.74
0.15
1.2
1.5
—
—
—
0
0
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
70
668
1.07
0.15
4.6
3.2
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
10
118
0.84
0.14
1.4
1.4
—
—
—
0
0
(3000492) Spirometry study
17
153
1.12
0.11
1.9
1.6
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
10
86
1.17
0.11
1.5
2.3
u/l
39.9
41.6
—
10
78
(40760888) Immunoglobulin light chains.free panel - Serum
5
47
1.07
0.09
10.8
5.0
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
22
204
1.09
0.09
3.3
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
5
64
0.78
0.08
7.2
2.0
g/l
35.5
36.6
—
5
55
(3018095) Leukocytes [#/volume] in Urine
67
653
1.04
0.06
5.0
3.9
e6/l
44.1
66.7
0.37
56
456
(3007164) IgA [Mass/volume] in Serum or Plasma
33
343
0.95
0.05
2.0
1.5
g/l
1.9
2.5
1.95
22
195
(36304419) Bacteria [Presence] in Urine
49
504
0.96
0.05
4.2
3.0
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
55
564
0.97
0.05
3.3
3.1
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
180
0.94
0.04
1.3
1.6
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
77
758
1.03
0.03
14.9
9.6
e9/l
0.0
0.0
0.88
71
627
(3030467) Casts [#/volume] in Urine by Automated count
53
523
1.02
0.01
4.1
3.1
e6/l
0.4
0.4
0.03
48
379
(21494755) Public health laboratory ask at order entry panel
11
114
0.96
0.00
1.4
1.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
19
191
0.99
0.00
2.2
2.3
ug/g
104.3
122.0
0.18
13
153
(3022621) pH of Urine by Test strip
13
127
1.03
0.00
5.0
2.8
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
36
365
0.98
0.00
1.1
1.2
u/ml
0.6
1.5
—
7
91
(36660697) Celiac disease serology panel - Serum
13
125
1.04
0.00
1.2
1.2
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
6.3
—
0
8
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
0
8
0.00
0.00
0.0
2.5
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
10.5
—
0
9
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
9
94
0.96
0.00
3.3
2.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
1430.8
—
0
6
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.8
—
1328.2
—
0
5
(3044007) Cell count panel - Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
97.8
—
0
5
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
4.6
—
900.2
—
0
5
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
5
59
0.84
0.00
7.2
2.1
g/l
0.0
0.0
—
5
54
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
6
65
0.92
0.00
12.8
4.0
—
3.3
—
0
7
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
5
58
0.86
0.00
7.2
2.1
g/l
0.0
0.0
—
5
53
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
5
58
0.86
0.00
7.2
2.1
g/l
0.0
0.0
—
5
53
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
0
6
0.00
0.00
0.0
1.2
—
143.3
—
0
6
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
7
71
0.99
0.00
1.7
2.0
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
7
72
0.97
0.00
2.1
3.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
0.3
—
0
5
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
7
79
0.88
0.00
5.4
2.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: ST19_OSTITIS_DENTAL_IMPLANT – Osteitis due to dental implant
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).